The method of embodiment 55, wherein the composition comprises between about 0.01% to about 20% by weight of the poloxamer, about 0.01% to about 15% by weight of the poloxamer, about 0.01% to about 10% by weight of the poloxamer, about 0.01% to about 7% by weight of the poloxamer, about 0.01% to about 5% by weight of the poloxamer, about 0.01% to about 3% by weight of the poloxamer, about 0.01% to about 2% by weight of the poloxamer, or about 0.01% to about 1% by weight of the poloxamer
Black CJ, Burr NE, Ford AC
Factors determining inadequate hypoglycaemia during insulin tolerance testing (ITT) after pituitary surgery
Many people find that the soothing sensation of warmth helps alleviate the discomfort and cramping often associated with constipation, providing a sense of relief even if it does not directly stimulate bowel movements
Treatment options for alcoholic and non-alcoholic fatty liver disease: a review
J.NandaA